Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Pathol Res Pract ; 247: 154559, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37210770

ABSTRACT

Interdigitating dendritic cell sarcoma is a very rare entity in the spectrum of histiocytic and dendritic cell neoplasms that mostly occurs in lymph nodes, generally presenting as solitary lymphadenopathy, but may affect every organ. Among extra nodal sites, cutaneous interdigitating dendritic cell sarcoma is exceedingly rare; to date, only 9 cases have been described in English literature. The mean age at diagnosis was 60 years, with a male-female ratio of 1,5 to 1; clinically, two different modalities of skin presentation have been reported: solitary, represented by a single red-brownish nodular lesion, or diffuse, characterized by multiple nodular lesions in one or more body districts. The extreme rarity of this sarcoma and its morphological similarity to other poorly differentiated tumors may lead to a delay in diagnosis; in particular, cutaneous localization may be difficult to differentiate from follicular dendritic cell sarcoma, Langerhans cell sarcoma, poorly differentiated squamous cell carcinoma and more generally sarcomatoid carcinoma, atypical fibroxanthoma, malignant melanoma and several sarcomas. Immunohistochemistry plays an important role in identifying this rare entity and formulating a correct histological diagnosis, fundamental requirement for choosing the best therapeutic approach. We report herein a further case of an 81-year-old Caucasian woman who presented to the Dermatology Department to remove an asymptomatic skin papule in the left temporal region, clinically diagnosed as dermatofibroma. The overall pathological and immunohistochemical features supported the diagnosis of a malignant dendritic cell tumor, consistent of interdigitating dendritic cell sarcoma.


Subject(s)
Carcinoma , Dendritic Cell Sarcoma, Interdigitating , Sarcoma , Skin Neoplasms , Soft Tissue Neoplasms , Humans , Male , Female , Middle Aged , Aged, 80 and over , Dendritic Cell Sarcoma, Interdigitating/diagnosis , Dendritic Cell Sarcoma, Interdigitating/pathology , Diagnosis, Differential , Skin Neoplasms/diagnosis , Sarcoma/diagnosis , Soft Tissue Neoplasms/diagnosis , Dendritic Cells , Carcinoma/diagnosis
2.
Brain Res Bull ; 108: 106-12, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25264157

ABSTRACT

Depression is a neuropsychiatric disorder that is commonly found in patients with Parkinson's disease (PD). Many studies have suggested that physical exercise can have an antidepressant effect by increasing the levels of brain-derived neurotrophic factor (BDNF), and may also prevent neurodegenerative disease. However, different forms of training may promote different changes in the brain. The aim of this study was to investigate the effects of two types of physical training on depressive-like behavior, and on the levels of proBDNF, BDNF, and its receptor, TrkB, in a mouse model of PD. C57BL/6 mice were subjected to 60 days of exercise: either running on a treadmill or performing a strength exercise. PD was induced by striatal administration of 6-OHDA 24h after the last physical exercise session. Seven days after 6-OHDA injection, depressive-like behavior and apomorphine-induced rotational behavior were evaluated. The levels of proBDNF, BDNF, and TRKB were measured in the striatum and the hippocampus of mice by immunoblotting assay. The 6-OHDA-treated animals showed a significant increase in immobility time and rotational behavior compared with the control group. In addition, significant decreases in the levels of proBDNF, BDNF, and its receptor, TrkB were observed in the 6-OHDA group. Both types of physical exercise prevented depressive-like behavior and restored the levels of proBDNF, BDNF, and TrkB in the striatum and hippocampus of mice administered 6-OHDA. Our results demonstrate that exercise training was effective for neuroprotection in the striatum and the hippocampus in an experimental model of PD.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Depression/metabolism , Depression/prevention & control , Exercise Therapy , Parkinson Disease/metabolism , Animals , Depression/etiology , Disease Models, Animal , Male , Mice , Mice, Inbred C57BL , Motor Activity , Oxidopamine/toxicity , Parkinson Disease/complications , Receptor, trkB/metabolism
3.
Braz J Med Biol Res ; 46(1): 14-20, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23314343

ABSTRACT

The objective of the present study was to investigate the effects of eccentric training on the activity of mitochondrial respiratory chain enzymes, oxidative stress, muscle damage, and inflammation of skeletal muscle. Eighteen male mice (CF1) weighing 30-35 g were randomly divided into 3 groups (N = 6): untrained, trained eccentric running (16°; TER), and trained running (0°) (TR), and were submitted to an 8-week training program. TER increased muscle oxidative capacity (succinate dehydrogenase and complexes I and II) in a manner similar to TR, and TER did not decrease oxidative damage (xylenol and creatine phosphate) but increased antioxidant enzyme activity (superoxide dismutase and catalase) similar to TR. Muscle damage (creatine kinase) and inflammation (myeloperoxidase) were not reduced by TER. In conclusion, we suggest that TER improves mitochondrial function but does not reduce oxidative stress, muscle damage, or inflammation induced by eccentric contractions.


Subject(s)
Mitochondria, Muscle/physiology , Muscle, Skeletal/physiology , Oxidative Stress/physiology , Physical Conditioning, Animal/physiology , Animals , Creatine Kinase/blood , Lipid Peroxidation/physiology , Male , Mice , Mitochondria, Muscle/metabolism , Muscle, Skeletal/metabolism , Oxidation-Reduction , Peroxidase/blood , Physical Exertion , Rats , Succinate Dehydrogenase/blood
4.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;46(1): 14-20, 11/jan. 2013. graf
Article in English | LILACS | ID: lil-665797

ABSTRACT

The objective of the present study was to investigate the effects of eccentric training on the activity of mitochondrial respiratory chain enzymes, oxidative stress, muscle damage, and inflammation of skeletal muscle. Eighteen male mice (CF1) weighing 30-35 g were randomly divided into 3 groups (N = 6): untrained, trained eccentric running (16°; TER), and trained running (0°) (TR), and were submitted to an 8-week training program. TER increased muscle oxidative capacity (succinate dehydrogenase and complexes I and II) in a manner similar to TR, and TER did not decrease oxidative damage (xylenol and creatine phosphate) but increased antioxidant enzyme activity (superoxide dismutase and catalase) similar to TR. Muscle damage (creatine kinase) and inflammation (myeloperoxidase) were not reduced by TER. In conclusion, we suggest that TER improves mitochondrial function but does not reduce oxidative stress, muscle damage, or inflammation induced by eccentric contractions.


Subject(s)
Animals , Male , Mice , Rats , Mitochondria, Muscle/physiology , Muscle, Skeletal/physiology , Oxidative Stress/physiology , Physical Conditioning, Animal/physiology , Creatine Kinase/blood , Lipid Peroxidation/physiology , Mitochondria, Muscle/metabolism , Muscle, Skeletal/metabolism , Oxidation-Reduction , Physical Exertion , Peroxidase/blood , Succinate Dehydrogenase/blood
6.
Cancer Genet Cytogenet ; 165(2): 106-13, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16527604

ABSTRACT

Deletion of chromosome arm 6q is a frequent karyotypic alteration found in a variety of cancers and lymphoproliferative disorders, including leukemia and lymphomas. We characterized 6q deletions in 35 malignant lymphomas, using conventional and molecular cytogenetic approaches, to define the deletion pattern of 6q in different histological types. Conventional cytogenetics revealed a 6q deletion in 46% of lymphomas, including two cases that showed 6q deletion as the sole chromosome anomaly. Interphase FISH analysis demonstrated allelic loss of 6q regions in 33 out of 35 cases (94.2%); the deletions were discontinuous, involving nonadjacent molecular regions. Although 6q deletion is a common event in all types of lymphomas, specific deletion patterns seem to characterize different histological types, suggesting that different tumor suppressor genes play different roles in different types of lymphomas. Two specific 6q regions deleted in diffuse large B cell lymphomas but not in follicular lymphomas may be implicated in the clinical transformation.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 6 , Hodgkin Disease/genetics , Lymphoma, Non-Hodgkin/genetics , Chromosomes, Artificial, Yeast , Humans , In Situ Hybridization, Fluorescence , Interphase , Karyotyping
7.
Mol Cell Neurosci ; 31(2): 218-31, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16219474

ABSTRACT

Phosphorylated p38 mitogen-activated protein kinase (p38MAPK), but not activated c-jun-N-terminal kinase (JNK), increases in the motor neurons of transgenic mice overexpressing ALS-linked SOD1 mutants at different stages of the disease. This effect is associated with a selective increase of phosphorylated MKK3-6, MKK4 and ASK1 and a concomitant upregulation of the TNFalpha receptors (TNFR1 and TNFR2), but not IL1beta and Fas receptors. Activation of both p38 MAPK and JNK occurs in the activated microglial cells of SOD1 mutant mice at the advanced stage of the disease; however, this effect is not accompanied by the concomitant activation of the upstream kinases ASK1 and MKK3,4,6, while both the TNFRs are overexpressed in these cells. No changes of the upstream p38MAPK cascade kinases or TNFRs occur in reactive astrocytes. These findings highlight the activation of a selective intracellular signaling pathway in the motor neurons of SOD1 mutant mice, which is likely implicated in their death.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Motor Neurons/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Signal Transduction/physiology , Spinal Cord/cytology , Tumor Necrosis Factor-alpha/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Disease Models, Animal , Disease Progression , Enzyme Activation , Humans , JNK Mitogen-Activated Protein Kinases/genetics , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Kinase 3/metabolism , MAP Kinase Kinase 6/metabolism , MAP Kinase Kinase Kinase 5/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Neurons/cytology , Motor Neurons/pathology , Phosphorylation , RNA, Messenger/metabolism , Receptors, Interleukin-1/genetics , Receptors, Interleukin-1/metabolism , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor, Type I , Spinal Cord/pathology , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Superoxide Dismutase-1 , Tumor Necrosis Factor Decoy Receptors , fas Receptor/genetics , fas Receptor/metabolism
8.
Pathologica ; 92(6): 503-15, 2000 Dec.
Article in Italian | MEDLINE | ID: mdl-11234301

ABSTRACT

Based on the histological criteria proposed by the REAL and adopted by the WHO Classification, 30 cases of MALT type lymphoma, 18 cases of diffuse large B cell lymphoma (DLCL), and 17 cases of DLCLs, associated with a MALT type, were identified in a series of 65 surgically treated primary gastric lymphomas. The clinical records of the patients were analyzed retrospectively and the resected specimens were immunostained for bcl-2, p53 and Ki-67. Primary gastric DLBCLs, with or without a MALT type component, disclosed a higher stage of local extension, a more frequent nodal involvement and a significantly worse survival than pure MALT types. High p53 expression and high proliferation rate correlated with the presence of a large cell component and appeared useful for its identification in mixed forms. Low bcl-2 expression discriminated DLCL from DLCL/MALT. Tumor size, stage and Mib-1 index revealed a value in predicting prognosis.


Subject(s)
Lymphoma, B-Cell, Marginal Zone/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Stomach Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Antigens, Bacterial/analysis , Antigens, CD/analysis , Antigens, Nuclear , Biomarkers, Tumor/analysis , Combined Modality Therapy , Female , Gastritis/complications , Gastritis/microbiology , Helicobacter Infections/complications , Helicobacter pylori/immunology , Humans , Italy/epidemiology , Keratins/analysis , Ki-67 Antigen/analysis , Life Tables , Lymphoma, B-Cell, Marginal Zone/chemistry , Lymphoma, B-Cell, Marginal Zone/mortality , Lymphoma, B-Cell, Marginal Zone/surgery , Lymphoma, B-Cell, Marginal Zone/therapy , Lymphoma, Large B-Cell, Diffuse/chemistry , Lymphoma, Large B-Cell, Diffuse/mortality , Lymphoma, Large B-Cell, Diffuse/surgery , Lymphoma, Large B-Cell, Diffuse/therapy , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Proteins/analysis , Neoplasm Staging , Nuclear Proteins/analysis , Phenotype , Proto-Oncogene Proteins c-bcl-2/analysis , Retrospective Studies , Stomach Neoplasms/chemistry , Stomach Neoplasms/mortality , Stomach Neoplasms/surgery , Stomach Neoplasms/therapy , Survival Analysis , Tumor Suppressor Protein p53/analysis
9.
Nucleic Acids Res ; 23(22): 4603-7, 1995 Nov 25.
Article in English | MEDLINE | ID: mdl-8524649

ABSTRACT

An approach was sought to increase the half-life and target cell specificity of antisense oligodeoxynucleotides (oligos). A monoclonal antibody (MAb) was derived from mice immunised with an oligo complementary to a region (1-20) of the HIV genome. This MAb exerts a protective effect on the oligo from the degradation induced by plasma exonucleases in vitro and in vivo. Moreover the anti-oligo MAb dissociates from the oligo in the presence of its complementary sequence to allow hybridization of the two complementary strands. To direct the oligo to CD4+ cells the anti-oligo MAb was cross-linked to an anti-CD4 MAb. The heteroaggregate determines a 5-fold increase in the cellular membrane binding of the oligo to CD4+ lymphocytes. These findings suggest a new approach to enhancing the therapeutic action and the target specificity of antisense oligodeoxynucleotides useful for the selective inhibition of HIV replication in vivo.


Subject(s)
Antibodies, Monoclonal/pharmacology , Antiviral Agents/pharmacology , CD4 Antigens/physiology , CD4-Positive T-Lymphocytes/virology , Genome, Viral , HIV/drug effects , Oligonucleotides, Antisense/pharmacology , Animals , Antiviral Agents/immunology , Antiviral Agents/pharmacokinetics , Base Sequence , CD4-Positive T-Lymphocytes/immunology , Cell Line , Exodeoxyribonucleases/blood , Exodeoxyribonucleases/isolation & purification , Female , HIV/genetics , HIV/immunology , Half-Life , Humans , Mice , Mice, Inbred BALB C/immunology , Mice, Inbred Strains/immunology , Molecular Sequence Data , Oligonucleotides, Antisense/immunology , Oligonucleotides, Antisense/pharmacokinetics
10.
Cell Biophys ; 24-25: 119-26, 1994.
Article in English | MEDLINE | ID: mdl-7736515

ABSTRACT

Even though the first monoclonal antibodies (MAbs) directed against tumor cells were produced 15 yr ago, the therapeutic application of immunoconjugates is still at the beginning. This is principally because of the enormous work that is required for the development of completely new therapeutic tools. An alternative could be to only use MAbs to improve conventional treatment such as chemotherapy. To this aim, a MAb directed against doxorubicin (DXR) was produced. DXR is an anthracycline antibiotic of which the clinical usefulness in cancer chemotherapy is limited by serious side effects, such as cardiomyopathy, bone marrow depression, and gastrointestinal tract mucositis. This toxicity was found to be reduced by treatment with the antidrug MAb, as shown by reduction in body weight loss and mortality of experimental mice. To improve the DXR therapeutic index, a bifunctional hybrid MAb (DOXER2), capable of simultaneously recognizing DXR and the epidermal growth factor (EGF) receptor, was produced. This reagent was found in vitro to increase the drug toxicity on the epidermoid carcinoma cell line A431, which overexpresses the EGF-R and, at the same time, to reduce DXR cytotoxicity on EGF-R negative cells. The effect of DOXER2 on the DXR biodistribution in vivo was also investigated. In mice previously injected ip with the DOXER2, the uptake of the drug, in comparison to the control group, was found to be reduced in the intestine and in myocardial tissue, and significantly increased in the tumor.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Antibodies, Monoclonal/therapeutic use , Biomarkers, Tumor/immunology , Carcinoma, Squamous Cell/therapy , Doxorubicin/immunology , ErbB Receptors/immunology , Vulvar Neoplasms/therapy , Animals , Antibody Specificity , Antidotes , Carcinoma, Squamous Cell/pathology , Cell Division/drug effects , Cell Division/immunology , Drug Administration Schedule , Female , Hybridomas/immunology , Injections , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Vulvar Neoplasms/pathology
11.
Oncogene ; 8(11): 2917-23, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8105438

ABSTRACT

A molecule that is immunologically related to the c-erbB-2 oncogene product (p185HER2/neu) was detected in the conditioned culture medium from neu-overexpressing tumor cell lines and in sera of advanced-stage breast carcinoma patients. Using a sensitive (in the range of 0.5 ng ml-1) double-determinant radioimmunoassay (DDIRMA) with two monoclonal antibodies (MAbs) directed against the neu extracellular domain (ECD), soluble oncoproteins were detected in supernatants from several neu-positive tumor cell lines, independent of the levels of membrane p185HER2 expression. The molecule detected did not react with a MAb directed against an intracytoplasmic epitope of the p185HER2. Western blot analysis of the concentrated supernatant revealed a protein of approximately 110 kDa molecular mass, which closely matches the predicted size of the glycosylated p185HER2 ECD. Immunoprecipitation of culture supernatant from cell surface-radioiodinated cells confirmed the 110 kDa molecular mass of the glycosylated shed protein, which migrated to 86 kDa after deglycosylation. Proteolytic cleavage of the p185HER2 molecule was demonstrated in release assays carried out with protease inhibitors. The combined use of leupeptin and EDTA completely inhibited release of the molecule. Analysis of sera from breast carcinoma patients and healthy donors by DDIRMA revealed the presence of soluble neu in 15% of pathologic sera but none of the normal sera. A good correlation was found between neu-overexpression in the primary tumor and the soluble marker in serum of patients with advanced disease; sera of early-stage patients were always negative, independent of neu-overexpression in the tumor. These results suggest the usefulness of soluble neu as an indicator of tumor aggressiveness but not as a diagnostic marker of breast cancer.


Subject(s)
ErbB Receptors/metabolism , Neoplasms/metabolism , Proto-Oncogene Proteins/metabolism , Biomarkers, Tumor/analysis , ErbB Receptors/blood , Female , Humans , Molecular Weight , Protease Inhibitors/pharmacology , Proto-Oncogene Proteins/blood , Receptor, ErbB-2 , Tumor Cells, Cultured
12.
Pflugers Arch ; 422(3): 287-94, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1488287

ABSTRACT

Single-channel currents from Na(+)-dependent K+ channels (KNa) were recorded from cell-attached and inside-out membrane patches of cultured avian trigeminal ganglion neurons by means of the patch-clamp technique. Single-channel properties, such as the high elementary conductance and the occurrence of sub-conductance levels, were unchanged after the patches had been excised from the cells, indicating that they are not under the control of soluble cytoplasmic factors. In cell-attached recordings at the cell resting potential the degree of KNa activity, measured as the probability of the channel being open, Po, was low in most cases (around 0.01) and similar to that observed in the inside-out configuration when the bath solution contained concentrations of Na+ around 30 mM and of K+ close to the physiological intracellular levels. However, in some cell-attached patches Po was high (around 0.2) and comparable to the values measured in cell-free recordings with high Na+ concentrations in the bath (100 mM). The excision of a high-activity patch in the presence of 30 mM Na+ resulted in a fall of Po in about 20 s, which is consistent with the wash-out of a soluble cytoplasmic molecule. After the excision, all KNa displayed a similar Na+ sensitivity, irrespective of the degree of activation observed in the cell-attached mode. In inside-out patches the Po values observed in the presence of either low or high concentrations of Na+ in bath solutions were not modified by internal Ca2+ (0.8-8.5 microM).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Electric Conductivity/physiology , Neurons/physiology , Potassium Channels/physiology , Sodium/physiology , Trigeminal Ganglion/physiology , Animals , Calcium/physiology , Cells, Cultured , Membrane Potentials , Quail , Trigeminal Ganglion/cytology
SELECTION OF CITATIONS
SEARCH DETAIL